Evidence map›Paper›PMID 33225946›Full record

ArticleCell communication and signaling : CCS2020

Tyrosine 192 within the SH2 domain of the Src-protein tyrosine kinase p56

Matthias Kästle, Camilla Merten, Roland Hartig, Thilo Kaehne, Ardiyanto Liaunardy-Jopeace, Nadine M Woessner, Wolfgang W Schamel, John James, Susana Minguet, Luca Simeoni and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Matthias KästleInstitute of Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Leipziger Str.44, Building 26, 39120, Magdeburg, Germany.
Camilla MertenInstitute of Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Leipziger Str.44, Building 26, 39120, Magdeburg, Germany.
Roland HartigInstitute of Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Leipziger Str.44, Building 26, 39120, Magdeburg, Germany.
Thilo KaehneInstitute of Experimental Internal Medicine, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.
Ardiyanto Liaunardy-JopeaceMolecular Immunity Unit, Department of Medicine, University of Cambridge, MRC-LMB, Cambridge, UK.
Nadine M WoessnerSpemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University Freiburg, Freiburg, Germany.
Wolfgang W SchamelFaculty of Biology, Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
John JamesMolecular Immunity Unit, Department of Medicine, University of Cambridge, MRC-LMB, Cambridge, UK.
Susana MinguetFaculty of Biology, Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
Luca SimeoniInstitute of Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Leipziger Str.44, Building 26, 39120, Magdeburg, Germany. Luca.simeoni@med.ovgu.de.
Burkhart SchravenInstitute of Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Leipziger Str.44, Building 26, 39120, Magdeburg, Germany. Burkhart.schraven@med.ovgu.de.ORCID 0000-0003-4321-7405
Otto-von-Guericke-Universität Magdeburg · DEUniversity of Freiburg · DEUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUpon engagement of the T-cell receptor (TCR), the Src-family protein tyrosine kinase p56Lck phosphorylates components of the TCR (e.g. the TCRζ chains), thereby initiating T-cell activation. The enzymatic activity of Lck is primarily regulated via reversible and dynamic phosphorylation of two tyrosine residues, Y394 and Y505. Lck possesses an additional highly conserved tyrosine Y192, located within the SH2 domain, whose role in T-cell activation is not fully understood.

methodsKnock-in mice expressing a phospho-mimetic (Y192E) form of Lck were generated. Cellular and biochemical characterization was performed to elucidate the function of Y192 in primary T cells. HEK 293T and Jurkat T cells were used for in vitro studies.

resultsCo-immunoprecipitation studies and biochemical analyses using T cells from Lck

conclusionsTaken together, phosphorylation of Y192 regulates Lck functions in T cells at least twofold, by preventing Lck association to CD45 and by modulating ligand-induced recruitment of Lck to the TCR. MAJOR

findingsOur data change the current view on the function of Y192 and suggest that Y192 also regulates Lck activity in a manner independent of Y505 phosphorylation. Video Abstract.

Indexed as

src Homology DomainsAmino Acid SequenceAnimalsCell Line, TumorHEK293 CellsHumansKineticsLeukocyte Common AntigensLymphocyte ActivationLymphocyte Specific Protein Tyrosine Kinase p56(lck)Mice, Inbred C57BLPhosphorylationProtein ConformationReceptors, Antigen, T-CellSpleenStructure-Activity RelationshipLeukocyte Common AntigensLymphocyte Specific Protein Tyrosine Kinase p56(lck)Receptors, Antigen, T-CellTyrosineZAP70 protein, humanZAP-70 Protein-Tyrosine KinaseKnock-in miceLckPLASignal transductionT-cell activationTCR signalingY192Zap70

Identifiers

PMID33225946
PMCPMC7682018
OpenAlexW3107681436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.